Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks.

Related Articles

Correction: The Rationale for Using Rifabutin in the Treatment of MDR and XDR Tuberculosis Outbreaks.

PLoS One. 2015;10(7):e0134190

Authors: Sirgel FA, Warren RM, Böttger EC, Klopper M, Victor TC, van Helden PD

Abstract
[This corrects the article DOI: 10.1371/journal.pone.0059414.].

PMID: 26197053 [PubMed - as supplied by publisher]